Press Coverage

Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth – safety and efficacy evaluation in a first-in-man pilot clinical study

Background: Research has shown the efficacy of hair growth factors in hair regrowth. We describe the
intradermal injections of a recombinant, bioengineered hair formulation, containing growth factors, into
the scalp skin, for enhancement of hair regrowth and evaluate its efficacy. 
Objectives: The objective of
this study was to assess the efficacy and safety of the hair growth factor formulation in reducing hair loss
and enhancing hair growth. 

Materialnd methods as: This was an open-label, prospective, single-arm
interventional pilot study in which 1000 patients were given intradermal injections of a hair formulation
into the scalp skin. The formulation contains vascular endothelial growth factor, basic fibroblast growth
factor, insulin-like growth factor, keratinocyte growth factor, thymosin β4, and copper tripeptide-1
suspended in a sterile injectable vehicle. Intradermal injections of this hair formulation were injected
into the scalp once every 3 weeks for a total of eight such sessions. Hair pull test was performed before
every session. Videomicroscopic and global images were taken at baseline, fourth session, eighth
session, and 2 months after the completion of the eight sessions. Relevant safety assessments through

physical examination, questionnaires, and appropriate laboratory examination were conducted through-
out the study. 

Results: Significant reduction in hair fall was seen in 83% of the patients on hair pull test.
Videomicroscopic image evaluation showed that most patients had a decrease in the number of vellus
hairs, increase in number of terminal hairs, and increase in shaft diameter. Seventy-five percent of the
patients believed that the hair injections were aiding the treatment of their hair loss, and it was also
beneficial in post-hair transplant patients. At 1 year, a statistically significant increase in total hair count
(P = 0.002) continued to be seen. Treatment was well tolerated. 

Conclusions: Intradermal injections of
this hair formulation may be a promising option for treating male as well as female patterns of hair loss.


For full article open PDF

man pilot clinical study.pdf

Book Online Appointment

About Doctor

Dr. Debraj Shome

Dr. Debraj Shome is Director and Co founder of The Esthetic Clinics. He has been rated amongst the top surgeons in India by multiple agencies. The Esthetic Clinics patients include many international and national celebrities who prefer to opt for facial cosmetic surgery and facial plastic surgery in Mumbai because The Esthetic Clinics has its headquarters there.

Find us on Facebook

Photo Gallery

Our Dermatology Clinics Across Mumbai

Dermatologists in Kandivali
Dermatologists in Andheri
Dermatologists in Bandra
Dermatologists in Mahim
Dermatologists in Parel
Dermatologists in Dadar
Dermatologists in Chembur
Dermatologists in Vile Parle
Dermatologists in Khar
Dermatologists in Santacruz
Dermatologists in Goregoan
Dermatologists in Malad
Dermatologists in Jogeshwari
Dermatologists in Borivali

Latest News & Press Releases

Subscribe our Newsletter for Latest Updates